PAI-1 Assays
PAI1 Monoclonal Antibody (MA-33H1F7) (MA1-40224)
PAI-1 modulates migration through cell surface receptors. PAI-1 binding... | Download Scientific Diagram
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance | Cell Death & Disease
Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells - ScienceDirect
A Role for Plasminogen Activator Inhibitor-1 in Obesity: From Pie to PAI? | Arteriosclerosis, Thrombosis, and Vascular Biology
Plasminogen Activator Inhibitor-1 Signaling Pathway - Creative Diagnostics
Complete plasminogen activator inhibitor 1 deficiency: MedlinePlus Genetics
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
Mouse PAI1 Total ELISA Kit (ab157529) | Abcam
![Recombinant Anti-PAI1 antibody [EPR21850-82] (ab222754) | Abcam](https://www.abcam.com/ps/products/222/ab222754/Images/ab222754-11-anti-pai1-epr21850-82-huvec-flow-cytometry.jpg "Recombinant Anti-PAI1 antibody [EPR21850-82] (ab222754) | Abcam")
Recombinant Anti-PAI1 antibody [EPR21850-82] (ab222754) | Abcam
PAI-1: An Integrator of Cell Signaling and Migration
Plasminogen Activator Inhibitor-1 Signaling Pathway - Creative Diagnostics
IJMS | Free Full-Text | Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis
JCI - Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity
IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?
LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy: Molecular Therapy
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs - ScienceDirect
Plasminogen activator inhibitor-1 (PAI-1) deficiency
Anti-PAI-1 Monoclonal Antibody Inhibits the Metastasis and Growth of Esophageal Squamous Cell Carcinoma
JCI - PAI1 mediates fibroblast–mast cell interactions in skin fibrosis
Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease. | Semantic Scholar
Schematic representation of PAI-1 action. PAI-1 not only inhibits local... | Download Scientific Diagram
